BioCryst 制药 BCRX
$7.69 +$0.06 (+0.79%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $7.71 +0.26%
开盘$7.81
昨收$7.63
当日区间$7.38 – $7.83
成交量5.21M
市值$1.98B
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数7
平均目标价$19.57+154.5% 较现价
- 买入 71%
- 持有 29%
最低 $11.00现价 $7.69均值 $19.57最高 $32.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$11.00至$32.00，平均为$19.15。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 21 Oct 2026 | TD Cowen | BUY | $30.00 |
| 9 Oct 2026 | BofA Securities | BUY | $15.00 |
| 8 Oct 2026 | RBC Capital | HOLD | $11.00 |
| 30 Sep 2026 | J.P. Morgan | HOLD | $13.00 |
| 10 Sep 2026 | RBC Capital | HOLD | $11.00 |
| 8 Sep 2026 | Needham | BUY | $16.00 |
| 6 Aug 2026 | Wedbush | BUY | $20.00 |
| 6 Aug 2026 | H.C. Wainwright | BUY | $32.00 |
| 5 Aug 2026 | TD Cowen | BUY | $30.00 |
| 5 Aug 2026 | Needham | BUY | $16.00 |
| 5 Aug 2026 | RBC Capital | BUY | $13.00 |
| 15 Jul 2026 | BofA Securities | BUY | $15.00 |
| 13 Jul 2026 | Wedbush | BUY | $21.00 |
| 13 Jul 2026 | J.P. Morgan | HOLD | $12.00 |
| 7 Jul 2026 | RBC Capital | BUY | $14.00 |
| 30 Jun 2026 | Cantor Fitzgerald | BUY | $29.00 |
| 30 Jun 2026 | Wedbush | BUY | $21.00 |
| 30 Jun 2026 | Needham | BUY | $16.00 |
| 30 Jun 2026 | H.C. Wainwright | BUY | $32.00 |
| 29 Jun 2026 | Needham | BUY | $16.00 |
暂无评论——快来第一个聊聊 BCRX。
登录后参与讨论。